CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
+63.01%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$372M
AUM Growth
+$372M
(+42%)
Cap. Flow
+$17.3M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
85.87%
Holding
28
New
2
Increased
12
Reduced
7
Closed
2
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$6.33M |
| 2 |
Larimar Therapeutics
LRMR
|
$6.08M |
| 3 |
Repare Therapeutics
RPTX
|
$5.13M |
| 4 |
Keros Therapeutics
KROS
|
$3.64M |
| 5 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$3.06M |
Top Sells
| 1 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$5.54M |
| 2 |
TSVT
2seventy bio
TSVT
|
$4.21M |
| 3 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$4.14M |
| 4 |
Nkarta
NKTX
|
$3.16M |
| 5 |
Entrada Therapeutics
TRDA
|
$1.99M |
Sector Composition
| 1 | Healthcare | 99.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXDX
1
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $94.5M | 25.42% | 1,601,785 -70,191 | -4% | -$4.14M |
|
|
2
Pliant Therapeutics
PLRX
$101M
| $71.2M | 19.15% | 3,409,758 +302,951 | +10% | +$6.33M |
|
3
Cullinan Oncology
CGEM
$445M
| $41.6M | 11.18% | 3,243,185 +195,576 | +6% | +$2.51M |
|
|
4
Repare Therapeutics
RPTX
$71.7M
| $37.2M | 10.01% | 3,069,847 +423,066 | +16% | +$5.13M |
|
|
VECT
5
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $24.7M | 6.65% | 4,119,572 +337,373 | +9% | +$2.02M |
|
6
Kezar Life Sciences
KZR
$28.9M
| $15.2M | 4.08% | 1,762,793 -78,000 | -4% | -$672K |
|
|
7
Larimar Therapeutics
LRMR
$310M
| $10.9M | 2.94% | 3,415,148 +1,900,000 | +125% | +$6.08M |
|
|
AKUS
8
DELISTED
Akouos, Inc. Common Stock
AKUS
| $8.71M | 2.34% | 1,288,358 +452,238 | +54% | +$3.06M |
|
|
TSVT
9
DELISTED
2seventy bio
TSVT
| $7.72M | 2.07% | 530,223 -289,449 | -35% | -$4.21M |
|
|
10
Keros Therapeutics
KROS
$618M
| $7.53M | 2.03% | 200,229 +96,800 | +94% | +$3.64M |
|
11
Compass Therapeutics
CMPX
$483M
| $6.45M | 1.73% | 2,829,712 | – | – |
|
|
OMGA
12
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $5.72M | 1.54% | 1,055,882 | – | – |
|
|
INZY
13
DELISTED
Inozyme Pharma
INZY
| $5.35M | 1.44% | 1,996,277 -37,525 | -2% | -$101K |
|
14
Precision BioSciences
DTIL
$57.8M
| $4.78M | 1.28% | 3,674,820 +671,069 | +22% | +$872K |
|
|
IMA
15
ImageneBio, Inc. Common Stock
IMA
$150M
| $4.31M | 1.16% | 1,214,304 +123,367 | +11% | +$438K |
|
|
GTHX
16
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $4.05M | 1.09% | 323,945 -443,290 | -58% | -$5.54M |
|
|
ORTX
17
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $3.99M | 1.07% | 7,987,396 +2,679,645 | +50% | +$1.34M |
|
|
EIGR
18
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.43M | 0.92% | 455,100 +265,100 | +140% | +$2M |
|
|
FRLN
19
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $3.37M | 0.91% | 4,814,419 -47,900 | -1% | -$33.5K |
|
20
Rallybio
RLYB
$22.4M
| $2.81M | 0.76% | +194,297 | New | +$2.81M |
|
|
ONCR
21
DELISTED
Oncorus, Inc.
ONCR
| $2.01M | 0.54% | 2,367,436 | – | – |
|
22
Corvus Pharmaceuticals
CRVS
$428M
| $1.95M | 0.52% | 2,384,402 +170,218 | +8% | +$139K |
|
23
Ovid Therapeutics
OVID
$91M
| $1.59M | 0.43% | 864,822 | – | – |
|
|
24
Nkarta
NKTX
$151M
| $1.55M | 0.42% | 117,599 -240,414 | -67% | -$3.16M |
|
25
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.5M
| $1.2M | 0.32% | +50,000 | New | +$1.2M |
|